Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2025-2031

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Growth (Status and Outlook) 2025-2031

The global Single Nucleotide Polymorphism (SNP) Genotyping market size is predicted to grow from US$ 24180 million in 2025 to US$ 79280 million in 2031; it is expected to grow at a CAGR of 21.9% from 2025 to 2031.

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Global Single Nucleotide Polymorphism (SNP) Genotyping key players include Illumina, Affymetrix, Applied Biosystems, Agilent Technologies, Beckman Coulter, etc. Global top five players hold a share about 65%.

North America is the largest market, with a share about 40%, followed by Europe and Japan, having a total share about 35 percent.

In terms of product, the segment includes Transversion, Transition. And in terms of application, the largest application is Diagnostics, followed by Animal, Plant, Research, etc.

LPI (LP Information)' newest research report, the “Single Nucleotide Polymorphism (SNP) Genotyping Industry Forecast” looks at past sales and reviews total world Single Nucleotide Polymorphism (SNP) Genotyping sales in 2024, providing a comprehensive analysis by region and market sector of projected Single Nucleotide Polymorphism (SNP) Genotyping sales for 2025 through 2031. With Single Nucleotide Polymorphism (SNP) Genotyping sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Nucleotide Polymorphism (SNP) Genotyping industry.

This Insight Report provides a comprehensive analysis of the global Single Nucleotide Polymorphism (SNP) Genotyping landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single Nucleotide Polymorphism (SNP) Genotyping portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single Nucleotide Polymorphism (SNP) Genotyping market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single Nucleotide Polymorphism (SNP) Genotyping and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single Nucleotide Polymorphism (SNP) Genotyping.

This report presents a comprehensive overview, market shares, and growth opportunities of Single Nucleotide Polymorphism (SNP) Genotyping market by product type, application, key players and key regions and countries.

Segmentation by Type:
Transversion
Transition

Segmentation by Application:
Diagnostics
Animal
Plant
Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.